APA (7th ed.) Citation

Li, Y., Mao, T., Wang, J., Zheng, H., Hu, Z., Cao, P., . . . Lin, F. (2023). Toward the next generation EGFR inhibitors: An overview of osimertinib resistance mediated by EGFR mutations in non-small cell lung cancer. Cell Communication & Signaling, 21(1), 1. https://doi.org/10.1186/s12964-023-01082-8

Chicago Style (17th ed.) Citation

Li, Yufeng, et al. "Toward the Next Generation EGFR Inhibitors: An Overview of Osimertinib Resistance Mediated by EGFR Mutations in Non-small Cell Lung Cancer." Cell Communication & Signaling 21, no. 1 (2023): 1. https://doi.org/10.1186/s12964-023-01082-8.

MLA (9th ed.) Citation

Li, Yufeng, et al. "Toward the Next Generation EGFR Inhibitors: An Overview of Osimertinib Resistance Mediated by EGFR Mutations in Non-small Cell Lung Cancer." Cell Communication & Signaling, vol. 21, no. 1, 2023, p. 1, https://doi.org/10.1186/s12964-023-01082-8.